Kate Anne Harrington
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kate Anne Harrington has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Emma Phelan
Radiology Department, Adelaide and Meath Hospital , Tallaght, Dublin , Ireland
2 shared publications- Michael Joseph Kerin
Discipline of Surgery, Lambe Institute for Translational Research, School of Medicine, University of Galway, H91TK33 Galway, Ireland
2 shared publications - Roisin M. Dwyer
School of Medicine Lambe Institute for Translational Research University of Galway H91 TK33 Galway Ireland
2 shared publications - Aoife J. Lowery
Discipline of Surgery, Lambe Institute for Translational Research, University of Galway, Galway, Ireland
1 shared publication Bobby Tang
Radiology Department, Adelaide and Meath Hospital , Tallaght, Dublin , Ireland
1 shared publicationCatherine E. Curran
National University of Ireland, Galway (N.U.I.G)
1 shared publication
Latest Publications
- 29 November 2018
- Published by Springer Nature in Skeletal Radiology
- Vol. 48 (5) , 823-830
Surface-type chondromyxoid fibroma in an elderly patient: a case report and literature review
Chondromyxoid fibroma (CMF) is a rare benign bone neoplasm that typically occurs in young adults. Juxtacortical or surface-type CMF are rarer still and we present the case of a surface-type CMF in a 78-year-old woman, with only one other case described in a patient of a similar age previously. This patient was an otherwise healthy woman who presented for evaluation of a palpable lump in the anterior proximal tibia. Initial radiographs obtained demonstrated a focal soft tissue fullness immediately anterior to the anterior cortex of the proximal tibia, which contained faint chondroid-like matrix internally. There was associated scalloping of the anterior tibial cortex. MRI confirmed the presence of a juxtacortical, enhancing lesion. Subsequent excisional biopsy was performed and histopathology demonstrated features, which was consistent with surface-type CMF. At a 6-month follow-up the patient remained free of recurrence. In a patient of this age, paraosteal chondrosarcoma should be excluded. Surface-type CMF, although rare, has been described in older patients and while it is unlikely to feature in a list of differential considerations on initial imaging, awareness of the entity is important.
- 29 November 2018
- Published by Springer Nature in Skeletal Radiology
- Vol. 48 (5) , 823-830
Surface-type chondromyxoid fibroma in an elderly patient: a case report and literature review
Chondromyxoid fibroma (CMF) is a rare benign bone neoplasm that typically occurs in young adults. Juxtacortical or surface-type CMF are rarer still and we present the case of a surface-type CMF in a 78-year-old woman, with only one other case described in a patient of a similar age previously. This patient was an otherwise healthy woman who presented for evaluation of a palpable lump in the anterior proximal tibia. Initial radiographs obtained demonstrated a focal soft tissue fullness immediately anterior to the anterior cortex of the proximal tibia, which contained faint chondroid-like matrix internally. There was associated scalloping of the anterior tibial cortex. MRI confirmed the presence of a juxtacortical, enhancing lesion. Subsequent excisional biopsy was performed and histopathology demonstrated features, which was consistent with surface-type CMF. At a 6-month follow-up the patient remained free of recurrence. In a patient of this age, paraosteal chondrosarcoma should be excluded. Surface-type CMF, although rare, has been described in older patients and while it is unlikely to feature in a list of differential considerations on initial imaging, awareness of the entity is important.
- 1 November 2018
- Published by Elsevier in Clinical Imaging
- Vol. 52, 180-182
Women in academic musculoskeletal radiology
- 1 November 2018
- Published by Elsevier in Clinical Imaging
- Vol. 52, 180-182
Women in academic musculoskeletal radiology
- 7 March 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1089) , 20170609
Computed tomographic evaluation of the thymus—does obesity affect thymic fatty involution in a healthy young adult population?
Objective:To determine a relationship between increased body mass index (BMI) and fatty involution of the thymus in subjects aged between 20 and 30 years.Methods:CT images of 94 patients aged betwe...
- 7 March 2018
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 91 (1089) , 20170609
Computed tomographic evaluation of the thymus—does obesity affect thymic fatty involution in a healthy young adult population?
Objective:To determine a relationship between increased body mass index (BMI) and fatty involution of the thymus in subjects aged between 20 and 30 years.Methods:CT images of 94 patients aged betwe...
- 1 February 2016
- Published by SAGE Publications in Canadian Association of Radiologists Journal
- Vol. 67 (1) , 76-81
The Management of the Symptomatic Patient with a Metal-on-Metal Hip Prosthesis
Metal-on-metal (MoM) hip implants have gained popularity due to their greater stability and reduction in implant failure compare to metal-on-polyethylene prostheses. However, as well as carrying general risks of hip implantation, risks specifically associated with MoM implants have been well documented in recent years. Conditions such as pseudotumours or aseptic lymphocyte-dominated vasculitis-associated lesions are specific to MoM hip implants. In this review we discuss the typical patient presentation, the investigations that should be performed, the typical findings on various imaging modalities, and the treatment options of symptomatic patients with MoM hip arthroplasties.
- 1 February 2016
- Published by SAGE Publications in Canadian Association of Radiologists Journal
- Vol. 67 (1) , 76-81
The Management of the Symptomatic Patient with a Metal-on-Metal Hip Prosthesis
Metal-on-metal (MoM) hip implants have gained popularity due to their greater stability and reduction in implant failure compare to metal-on-polyethylene prostheses. However, as well as carrying general risks of hip implantation, risks specifically associated with MoM implants have been well documented in recent years. Conditions such as pseudotumours or aseptic lymphocyte-dominated vasculitis-associated lesions are specific to MoM hip implants. In this review we discuss the typical patient presentation, the investigations that should be performed, the typical findings on various imaging modalities, and the treatment options of symptomatic patients with MoM hip arthroplasties.
- Open Access
- 4 June 2008
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 115 (2) , 279-287
Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones
Introduction The chemokines Stromal Cell-Derived Factor-1α (SDF-1α/CXCL12) and Monocyte Chemotactic Protein-1 (MCP-1/CCL2) have been implicated in breast cancer progression. We recently reported elevated systemic MCP-1 in breast cancer patients. This study investigated circulating levels of SDF-1α in breast cancer patients, and addressed potential hormonal regulation of these two potent chemokines. Methods SDF-1α levels were determined by ELISA in 114 breast cancer patients and 85 controls, and correlated with clinical data. Blood samples were collected from 36 healthy premenopausal volunteers weekly for four weeks to measure Luteinising Hormone (LH), Follicular Stimulating Hormone (FSH), Oestradiol and Progesterone using a Bayer ADVIA® Centaur Immunoassay system, in parallel with SDF-1α and MCP-1. CXCL12 expression was determined using RQ-PCR in primary tumour stromal cells (n = 16) harvested at surgery. Results Plasma SDF-1α was significantly higher in breast cancer patients than age-matched controls and had a significant correlation with tumour grade and epithelial subtype. Investigation of menstrual variations of these chemokines revealed lower SDF-1α levels in the mid-luteal phase of the menstrual cycle and a significant positive correlation with circulating Oestradiol. MCP-1 levels showed no correlation with menstrual hormones. There was a trend towards increased CXCL12 expression in tumour compared to normal stromal cells. Conclusions The elevated level of SDF-1α detected in breast cancer patients, and it’s correlation with prognostic indicators, highlights the importance of this chemokine in disease progression. Elucidation of factors influencing chemokine secretion supports clarification of their role in tumourigenesis.
- 4 June 2008
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 115 (2) , 279-287
Open AccessSystemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones
Introduction The chemokines Stromal Cell-Derived Factor-1α (SDF-1α/CXCL12) and Monocyte Chemotactic Protein-1 (MCP-1/CCL2) have been implicated in breast cancer progression. We recently reported elevated systemic MCP-1 in breast cancer patients. This study investigated circulating levels of SDF-1α in breast cancer patients, and addressed potential hormonal regulation of these two potent chemokines. Methods SDF-1α levels were determined by ELISA in 114 breast cancer patients and 85 controls, and correlated with clinical data. Blood samples were collected from 36 healthy premenopausal volunteers weekly for four weeks to measure Luteinising Hormone (LH), Follicular Stimulating Hormone (FSH), Oestradiol and Progesterone using a Bayer ADVIA® Centaur Immunoassay system, in parallel with SDF-1α and MCP-1. CXCL12 expression was determined using RQ-PCR in primary tumour stromal cells (n = 16) harvested at surgery. Results Plasma SDF-1α was significantly higher in breast cancer patients than age-matched controls and had a significant correlation with tumour grade and epithelial subtype. Investigation of menstrual variations of these chemokines revealed lower SDF-1α levels in the mid-luteal phase of the menstrual cycle and a significant positive correlation with circulating Oestradiol. MCP-1 levels showed no correlation with menstrual hormones. There was a trend towards increased CXCL12 expression in tumour compared to normal stromal cells. Conclusions The elevated level of SDF-1α detected in breast cancer patients, and it’s correlation with prognostic indicators, highlights the importance of this chemokine in disease progression. Elucidation of factors influencing chemokine secretion supports clarification of their role in tumourigenesis.
- Open Access
- 1 September 2007
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (17) , 5020-5027
Monocyte Chemotactic Protein-1 Secreted by Primary Breast Tumors Stimulates Migration of Mesenchymal Stem Cells
Purpose: Major barriers to effective adenovirus-based gene therapy include induction of an immune response and tumor-specific targeting of vectors. The use of mesenchymal stem cells (MSC) as systemic delivery vehicles for therapeutic genes has been proposed as a result of their combined ability to home in on the tumor site and evade the host immune response. This study is aimed at investigating factors mediating homing of human MSCs to breast cancer primary cultures and cell lines in vitro and in vivo.
- 1 September 2007
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (17) , 5020-5027
Open AccessMonocyte Chemotactic Protein-1 Secreted by Primary Breast Tumors Stimulates Migration of Mesenchymal Stem Cells
Purpose: Major barriers to effective adenovirus-based gene therapy include induction of an immune response and tumor-specific targeting of vectors. The use of mesenchymal stem cells (MSC) as systemic delivery vehicles for therapeutic genes has been proposed as a result of their combined ability to home in on the tumor site and evade the host immune response. This study is aimed at investigating factors mediating homing of human MSCs to breast cancer primary cultures and cell lines in vitro and in vivo.